about
Emerging Approaches to Tuberculosis Drug Development: At Home in the Metabolome.Modulation of Mycobacterium tuberculosis-specific humoral immune responses is associated with Strongyloides stercoralis co-infectionWhat We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan".Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.The N-Glycosylation of Mouse Immunoglobulin G (IgG)-Fragment Crystallizable Differs Between IgG Subclasses and Strains.Molecular signatures of neutrophil extracellular traps in human visceral leishmaniasis.Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.Humoral Responses to Rv1733c, Rv0081, Rv1735c, and Rv1737c DosR Regulon-Encoded Proteins of Mycobacterium tuberculosis in Individuals with Latent Tuberculosis Infection.Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.The Role of BAFF System Molecules in Host Response to Pathogens.New synthetic lipid antigens for rapid serological diagnosis of tuberculosis.Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.Pathways and Genes Associated with Immune Dysfunction in Sheep Paratuberculosis.Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.What Have We Learnt about BCG Vaccination in the Last 20 Years?The Recombinant Bacille Calmette-Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing.Non-pathological infection of macaques by an attenuated mycobacterial vaccine is not reactivated in the setting of HIV coinfection.A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan.Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine.Systems serology: profiling vaccine induced humoral immunity against HIV.Tuberculosis: Just the FAQs.Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model.Potential Diagnostic Power of Blood Circular RNA Expression in Active Pulmonary Tuberculosis.Prospects from systems serology research.HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells.IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals.Beyond binding: antibody effector functions in infectious diseases.Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis.A significant therapeutic effect of immunoglobulins administered alone, or in combination with conventional chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains.Next-Generation Vaccines Based on Bacille Calmette-Guérin.Th1 cytokines, true functional signatures for protective immunity against TB?Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults.Functional and Phenotypic Changes of Natural Killer Cells in Whole Blood during Mycobacterium tuberculosis Infection and Disease.Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen.Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin.Float Like Bacilli, STING Like a B: Type I Interferons in Tuberculosis.
P2860
Q30236042-8FA643E7-7D14-4784-A3AF-82A3A8E41077Q33664416-079F06D4-4AA7-479F-A27C-96B67D028114Q33679240-F825C8E2-4F08-49EB-A5D3-3221C057B127Q33719289-58E6D42A-FFCD-4818-ADCD-70F7107BEAF9Q33740762-8A661A52-FB2E-4C33-9FB5-F8C1D1273EA3Q33767985-ABEB3FCF-6352-43EA-98FE-40478A913924Q36229621-34FD9903-7991-4280-98B2-76C7FE993036Q36302781-72A5C639-B3A8-4FBC-A29B-072DD65EA97FQ37642329-0E4AC311-1510-4980-91EA-5690FB9D6A10Q37717814-AF7EB4CE-D5F7-4DC7-B85F-C776A084F896Q37737549-22531CE7-27AD-4394-B181-5DB402685EA5Q38601694-8385163D-CFFC-4269-B4E2-E2816C25BDF5Q39110074-1BEDCDD5-DD23-4249-B029-A55C90607E04Q40116835-12C103DB-E5F1-4B82-865A-C2ED9C5EB09CQ40240403-F4BC1147-DA48-471E-9035-0D57599E2AABQ40457681-1BC6E883-014F-4F79-9083-64C42C617CE7Q41684091-A11834DE-1C3C-4E94-9256-81BCCDA0A6E6Q41836016-C81D4F74-34C1-4805-BF29-AD5A9F20961BQ41932554-5555D835-1874-406A-9EEF-D41BAC05AF68Q42370800-226CF55E-C322-4AD3-80A7-3E0165318821Q44168441-2139ECF0-7B3A-4BAA-8848-F31B79666F56Q47104983-0F8C8D30-5671-469C-92A8-5CCB56234A47Q47159580-0D52E686-10DD-424E-9487-156FED7E45E0Q47220975-D2BCC543-D995-4DCE-B69C-4938FA8E483CQ47221323-55AE4282-5672-4EFF-B2D7-E38897CC68D0Q47243124-D8963E05-7907-4410-B0C0-2C6EB5F34919Q47346211-31897728-8503-40F4-9153-E5DF4D32CAF6Q47399269-6AEA300B-0C72-447E-B146-61AD8FADA794Q47556035-3CBB40AA-EDA5-4299-B061-8CAEC6148A7CQ47602559-6D907DAC-3F2D-438D-A76C-73486BDD0C11Q48232204-25FEC0EE-04C1-4D17-BC05-CA8B28C319C8Q49549718-59D2E575-237F-42F6-B81F-7422F320FC68Q49829375-14D7DAD2-5874-4968-AAFC-2FD7DB7C8BB9Q49900955-A460E264-463B-4D01-A032-9D926E0DF872Q50140660-416F7295-C41B-4F50-BDFE-E93BD81848B2Q50531642-A1262992-3C36-4467-A832-0E4F698F7937Q50531820-3BA193D4-BDC8-4D95-995E-D6833F999091Q52334135-B47198D0-97D6-4E60-B279-2C00AFA5574FQ52338712-98CAFD40-26A2-4027-93D2-C0F9063BFB3FQ52742587-63AC0C00-E03D-4CAE-8597-D7A88A7031BD
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Functional Role for Antibodies in Tuberculosis.
@en
A Functional Role for Antibodies in Tuberculosis.
@nl
type
label
A Functional Role for Antibodies in Tuberculosis.
@en
A Functional Role for Antibodies in Tuberculosis.
@nl
prefLabel
A Functional Role for Antibodies in Tuberculosis.
@en
A Functional Role for Antibodies in Tuberculosis.
@nl
P2093
P2860
P50
P1433
P1476
A Functional Role for Antibodies in Tuberculosis.
@en
P2093
Alison E Mahan
Blanca I Restrepo
Cheryl Day
Constance Martin
Elizabeth Tkachenko
Fikadu Tafesse
Galit Alter
Hannah Robinson
Jacquelynne Tedesco
Katherine J Freedberg
P2860
P304
433-443.e14
P356
10.1016/J.CELL.2016.08.072
P407
P577
2016-09-21T00:00:00Z